The role of dendritic cells at the early stages of Leishmania infection

Advances in Experimental Medicine and Biology

Volumn 479, Issue , 2000, Pages 163-173

  Moll, H ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ADOPTIVE IMMUNOTHERAPY; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; CLINICAL FEATURE; CONFERENCE PAPER; DENDRITIC CELL; IMMUNE RESPONSE; IMMUNITY; LANGERHANS CELL; LEISHMANIA; LEISHMANIASIS; MACROPHAGE; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; TH2 CELL;

ANIMALS; ANTIGEN-PRESENTING CELLS; CELL TRANSPLANTATION; DENDRITIC CELLS; HUMANS; LEISHMANIASIS; MACROPHAGES; PHAGOCYTOSIS; VACCINATION;

EID: 0034475145     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (50)

1. Human dendritic cell (DC)-based anti-infective therapy: Engineered DCs to secrete functional IFN-γ and IL-12
2. DNA vaccination: Transfection and activation of dendritic cells as key events for immunity
3. Dendritic cells and the control of immunity
4. Analysis of cytokine production by inflammatory mouse macrophages at the single-cell level: Selective impairment of IL-12 induction in Leishmania-infected cells
5. Murine epidermal Langerhans cells do not express inducible nitric oxide synthase
6. Parasitism of epidermal Langerhans cells in experimental cutaneous leishmaniasis with Leishmania major
7. Immunization through dermal delivery of protein-encoding DNA: A role for migratory dendritic cells
8. Murine dendritic cells pulsed in vitro with Toxoplasma gondii antigens induce protective immunity in vivo
9. Leishmania promastigotes selectively inhibit interleukin 12 induction in bone marrow-derived macrophages from susceptible and resistant mice
10. DNA-based immunization by in vivo transfection of dendritic cells
11. Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo
12. Effects of interleukin-10 on dendritic cell maturation and function
13. Intracellular Leishmania amazonensis amastigotes internalize and degrade MHC class II molecules of their host cells
14. Inhibition of Langerhans cell antigen-presenting functions by IL-10: A role for IL-10 in induction of tolerance
15. Human dendritic cells phagocytose and process Borrelia burgdorferi
16. Antigen-pulsed epidermal Langerhans cells protect susceptible mice from infection with the intracellular parasite Leishmania major
17. Synthesis, stability, and subcellular distribution of major histocompatibility complex class II molecules in Langerhans cells infected with Leishmania major
18. Leishmania major interferes with antigen presentation by infected macrophages
19. Dendritic cells, but not macrophages, produce IL-12 immediately following Leishmania donovani infection
20. Invasion and intracellular survival of Bordetella bronchiseptica in mouse dendritic cells
21. Interaction of Listeria monocytogenes with mouse dendritic cells
22. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells
23. Dendritic cell progenitors phagocytose particulates, including Bacillus Calmette-Guerin organisms, and sensitize mice to mycobacterial antigens in vivo
24. Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: A role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA
25. Deficient expression of co-stimulatory molecules on Leishmania-infected macrophages
26. Virus interactions with dendritic cells
27. Murine dendritic cells internalize Leishmania major promastigotes, produce IL-12 p40 and stimulate primary T cell proliferation in vitro
28. IL-4-deficient BALB/c mice resist infection with Leishmania major
29. + T cells that are NK1.1
30. + dendritic cells initiating cytokine expression
31. Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response
32. Bone marrow-derived denedritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumor immunity
33. Borrelia burgdorferi-pulsed dendritic cells induce a protective immune response against tick-transmitted spirochetes
34. Epidermal Langerhans cells are critical for immunoregulation of cutaneous leishmaniasis
35. Dendritic cells in Leishmania major-immune mice harbor persistent parasites and mediate an antigen-specific T cell immune response
36. Langerhans cells transport Leishmania major from the infected skin to the draining lymph node for presentation to antigen-specific T cells
37. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells
38. Internalization of Chlamydia by dendritic cells and stimulation of Chlamydia-specific T cells
39. The CDI system: Antigen-presenting molecules for T cell recognition of lipids and glycolipids
40. Antigen presentation capacity of murine macrophages infected with Leishmania amazonensis amastigotes
41. Parasite-accessory cell interactions in murine leishmanisis. II. Leishmania donovani suppresses macrophage expression of class I and class II major histocompatibility complex gene products
42. The regulation of immunity to Leishmania major
43. -T cells during initiation of infection
44. In vivo microbial stimulation induces rapid CD40L-independent production of IL-12 by dendritic cells and their re-distribution to T cell areas
45. Dendritic cell survival maturation are regulated by different signalling pathways
46. IL-12 is required for natural killer cell activation and subsequent T helper I cell development in experimental leishmaniasis
47. Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells
48. Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania major
49. Vaccination against chlamydial genital tract infection after immunization with dendritic cells pulsed ex vivo with nonviable chlamydiae
50. Uptake of Leishmania major amastigotes results in activation and interleukin 12 release from murine skin-derived dendritic cells: Implications for the initiation of anti-Leishmania immunity